CANADA LIFE ASSURANCE Co
InsurancePosition in NBIX — Neurocrine Biosciences Inc
CIK 1046192
WINNIPEG, A2
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,239,880
+$2,678,060 QoQ
Shares Held
72,623
+0.1% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#143
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $112,895,525 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
378,539 | $27,201,812 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
39,673 | $21,496,021 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
608,637 | $20,620,621 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
72,623 | $12,239,880 | |
| 5 | VTRS |
Viatris Inc
|
505,084 | $8,020,733 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
285,889 | $7,035,728 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
38,087 | $4,225,371 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
140,778 | $2,436,867 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,239,880 | 72,623 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,561,820 | 72,581 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,215,022 | 72,023 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,246,195 | 72,989 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $9,443,843 | 75,136 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,886,423 | 89,389 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,801,243 | 93,782 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,611,065 | 100,773 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,621,723 | 91,681 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,089,181 | 80,403 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,241,367 | 85,317 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $10,351,912 | 92,017 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,204,623 | 97,610 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,011,467 | 98,908 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,919,753 | 99,797 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $10,347,403 | 97,424 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $10,244,270 | 105,091 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $9,275,437 | 98,938 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,953,070 | 105,120 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,296,640 | 76,078 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,623,112 | 68,055 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $7,177,341 | 73,803 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,404,400 | 35,518 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,991,216 | 41,506 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $4,388,340 | 35,970 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,767,782 | 31,979 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||